Press Releases
2008
November
11/10/2008XOMA Reports Third Quarter 2008 Financial Results
11/10/2008
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
11/04/2008
XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10
11/04/2008
XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11
October
10/28/2008XOMA Appoints Steve Doberstein to Vice President of Research
10/25/2008
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
10/23/2008
XOMA to Present At the BIO Investor Forum On October 30
10/22/2008
XOMA Enters Into $60 Million Committed Equity Financing Facility
September
09/22/2008XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25
09/16/2008
XOMA to Present At the UBS Global Life Sciences Conference On September 22
09/15/2008
New Programs Added in Antibody Collaboration Between XOMA and Takeda
09/10/2008
Texas A&M University System and XOMA Sign Memorandum of Understanding
09/09/2008
XOMA Awarded $65 Million Biodefense Contract by NIAID to Advance Drug Candidates Against Botulism Toxins Into Clinical Trials
09/08/2008
XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Targeting Inflammatory Damage to Insulin-Producing Cells
August
08/07/2008XOMA Reports Second Quarter 2008 Financial Results
08/04/2008
XOMA to Announce Second Quarter 2008 Financial Results and Host Conference Call On Thursday, August 7
July
07/28/2008XOMA Announces Departure of CFO
07/24/2008
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical Gel as a Treatment for the Common Skin Disease, Impetigo
07/15/2008
XOMA 052 Phase 1 Data to be Presented At European Association for the Study of Diabetes Annual Meeting
June
06/19/2008XOMA to Present At the Jefferies Healthcare Conference On June 26
06/07/2008
XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS
06/07/2008
XOMA 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At ADA
06/05/2008
XOMA to Present At the Needham Biotechnology and Medical Technology Conference On June 11
May
05/14/2008XOMA to Present At the Rodman and Renshaw Global Healthcare Conference On May 20
05/12/2008
XOMA Refinances Royalty-Based Loan Facility for $55 Million
05/12/2008
XOMA Reports First Quarter 2008 Financial Results
05/05/2008
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12
April
04/01/2008XOMA Announces New Audit Committee Member
March
03/12/2008XOMA to Present At Cowen Health Care Conference On March 17
03/11/2008
XOMA Reports 2007 Results
03/10/2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development
03/04/2008
XOMA to Announce 2007 Financial Results and Host Conference Call On Tuesday, March 11
February
02/27/2008XOMA to Present At Susquehanna Financial Group Healthcare Conference On March 4
02/04/2008
XOMA to Present At BIO CEO and Investor Conference On February 11
January
01/18/2008XOMA Appoints W. Denman Van Ness as Lead Independent Director
2007
December
12/06/2007XOMA Speaks On Diabetes and Obesity Panel At RBC Capital Markets Healthcare Conference
November
11/26/2007XOMA Announces Conference Call to Provide Overview of Business Strategy
11/15/2007
XOMA to Present At Lazard Capital Markets Healthcare Conference On November 27
11/08/2007
XOMA Reports Third Quarter 2007 Financial Results
11/01/2007
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8
October
10/30/2007XOMA to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
